46287-030Level 3
ATORVALIQ (ATORVALIQ)
**Product type:** Human Prescription Drug
**Active ingredient:** ATORVASTATIN CALCIUM TRIHYDRATE
**Strength:** 20 mg/5mL
**Dosage form:** Suspension
**Route:** Oral
**Labeler:** CMP Pharma, Inc.
**Marketing category:** NDA (NDA213260)
**Pharmacologic class:** HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
GET
/api/v1/systems/ndc_fda/nodes/46287-030Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.